We begin with a diagnostic phase, where we deeply review your scientific data, regulatory gaps, market landscape and internal objectives. Based on that, we design a tailored roadmap combining clinical, regulatory and pharmaco-economic streams. At each milestone, we perform cross-functional reviews and decision gates to keep the strategy aligned, scientifically sound and adaptable to new findings.